UNGEN DAVIES CA14CER FUND CIO Charity reglstration number 11fj0922 ANIIUAL REPORT AMD FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2022
UNGEN DAVIES CANCER FUND CIO LEGAL AND ADMINISTRATIVE INFORMATION Mr5 AJ Thom MBE DL IChairrr*n) MrA Kli ley (WKe Gh8iTmanl Mrs C H Thom ITre8suwI Dr N N Srihari Dr G Eatough Mr D Jacksc MrsA Kenny Mrs F K Huich&son MrT cr Mrc LÈ8ke Mrs J L Bsaver Mrs V A Edwards Dr J R j¢)hrtsC MBE Charity number 1161)W22 Principal address Fundrdising Office rJo Hamar Centre Royal Shrewsbjry Hospital North Shrevlsbury Shropshire SY3 8XQ Auditor Emstrey Fb)use Shrewsbury Business Park shrSry SY2 fjLG aankers Santander PLC Bridle Road B¢xbde Merseysm L30 4GB Uoyds Bank PLC 2138 Coventy Road Sheldon 8imiirKJham B26 IJW Viryin Money PLC Jubilee Housè NewGasUe upon TYT NE3 4PL
LINGEN DAVIES CANCER FUND CIO TRUSTEES. REPORT FOR THE YEAR ENDED 31 MARCH 2022 The Trustee5 present thwr arwj accnts for the year erthl 31 Marth 2022. The fin8n¢ial statements have been prepe in accordance ¥ilh the aLU)ullting set out in note 1 to the financial statements arKI WTnFAy wrth the tharitys goveming do(xJtll8nL the Charibes Act 2011 Ènd 'Accounting and RepcTrrbng by Charities.. Statement of Recommended Practice applI(%1e to charitses preparing thalr accounts in accordance wth the Financial Rewting Standard applicaNe in Ihe UK aFKI Republic of Ireland IFRS 102)" las rnended accounting peric¥Js (winwong 1 JanLOry 20191. Obje¢tbves and actF¥ities Lingen Davies exists to enhance ncer serwces and improve lives. here in our cxjmnwnty. In line vthh ryJT consbtUti. the object of Ihe tharity i8: (al The relief. Olty or mainty of nCer patienls resKlirvJ in Shrtjpshire. Telford and Wreknn and Mid Wales {the charity's area) in pathul8r trt not exdusivdy by provmling: lil Gtsnts to support the work of IWK%I hea11hca professionats. based wilh5n and serving can(x patients in the charitys area and lill SeNces dir8d to (*ncer patients rf the Twstees deem appropriate Ib} The prevention of canw by r8isM)g aWarer in the charyiys arèa Notw"thstarKling that these may also benefft yyne n1n0nnCer palients residing oulside the ch8ritys area. The TTusle8s havè paid due regard lo gu1a tswed by the Charity Commtssion in deciding what acttvities the charity should undertakè. The Tnjstees consKler the objeetives and acalvit of the are of a b8n9fft. Athvitie$ of th• Charlty Lingen Davies exists to enhance cancer serViS arml improve INes in Shropshire. Tetrord & Wrekin. and Mid Wales. We do this through Iwo m8in streams ofwork. Grant making The charity rais8s fijnds for projects which a &sItiVe drfferen¢x lo thè lives of people INing wtth canr in Shropshire. Teword & Wrekin and Mtd Wales. Donation5 are made lo local hospitals. tharities. and other bod%es to assist with purchasing specialist equipment. imk¥owr¥J treatment spa(£s aThJ supporting communty-based projects to improve the health and wdlbeing of peop Imng th and beyond 1cr. Grant applications are assessed by the Grants Commiitee. a su1)Mmrttee of the Tnjstee Board, and then confirmed by the tnjstees Whe the value of the grant requires this. Grants are assessed against the aims and objects oflhe cknarity, ensuring that the proFwl shows a dear benefit to car pathents and servi. Close MTnun1(Xts.0n is maintained wtth grant CipIents to ensure that Ihe grant maknng priKess is as su(tessful as possible and achieves maximum pU1C benefil.
LINGEN DAVIES CANCER FUND CIO, CONTENTS TTUStee5' report ststement of Trustees. reskX)nsibi1eS Independent auditorfs report 10-12 Slatement of fmanrAal aGtrti&s 13 Balance sheet 14 St8t8ment of cash fk)ws 15 Noles to the financia stalerts 16-28
LINGEN DAVIES CANCER FUND CIO TRUSTEES. REPORT (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2022 Ser¥l¢e Delivery Our LiveLife project has really got off the ground year. as Covi(P19 Testriclions hav8 eased and publ events have been running as rK)rrn818gain. We have been running public hth awafeness camp8ign5, linking in wrth nath)nal and regi(Fnal scrèening campavJns arKI aXF4orirwJ C$05 ts Gommtssioning our (Y•vn mndinical support sérvices for people wtth cancer. We are worknng with local consultarw CamFthII Charfes Partnèrship lo evaluate the cxjrrent Provision of social and emoEw)nal support serVIS available to people affeckny by txrw in our re9. a eW to looknng at W8yS to fill gaps in provisi¢)n, whafe these bewme app8renL Wg are also ex131ed to be w<g in partnership NHS Shropshire. Telford and Wrthn to ddiver the Cfft20+ projecL This project is designed to inCaSe the uptake of (ancer SCTeening rn Communie$ who are less likely to engage sn the screening progrdmmes", partiujlarfy fcoissiNJ on people tsS1ing into the 20% mosl deprived communities in the UK. We wll be delNering this pro1t in Telford & wkIn arKI h8ve nIty app(MrFted 3 Cancer Champion Cwrdinalor. who 11 joining the team in Juty 2022 to lead on this woiect. We are continuing dis(aJs&ons Powys Tèaching Heatth Board, wth a vsew to launthing a project supportirrfJ peoplè living with cancer in Powys. using rneY left to Ihe chartty by a very geneTWS legator. We are hoping to launch this in 2022. This qUiCY becoming a major stream ol for us. vth the seNice beiro exlretnety busy this y8ar. We aTe now slruggling to fvlfil demand and make the rrKJSt of the opw)rtuntb"ès available to us. so we are looking to expand this team in 2022. Fundraising Actlvltles Following a very ¢h8118nging 2020121 due to the impact of Covi&19. we are very pleased to report that we have had a iewrd-breaksng year for fijndraising, wTih a total income of £1.077.07212021= £718.8871. This is the first time the charity has broken the £1m mark 8nd is sc¥mething w8 working hard kn. for the last fve years. We are v8ry proud of this, and it is lestament to the hard work of our staff team and wonderful vduntèers and supporters, who have rallied round lo &nsJJre our maF)r appeal, to fund a rthv CT Scanner and extension to the clinic rooms. was com#eted before Ihe rewsed dead11r of 31 March 2022. The challenges presented by the pandemic gave Ihe opportunty to rewew and reftect on wr fundraising PTacti¢ss and sped up the process of diver5ty.ng ujr fijndraising adivibes. Our major events programme 15 now back in full swing and b3ger than ever. and we have put muth more time into income streams such as CDrporate engagement and buildiThJ relationships vthh trusts arHJ fouThJations. We ate acutely aware ot hjrther Challere5 in the fijlure, IrudIng the oryoing impacls of BreKit. the war In Ukraine, the Covid-19 pandemic anil the global eo)nofflic uftcertainty this (xeates. We need to make sure that our income is sustainable in the firture. There are number of large donatmxts vrithin this overall total. and we are not naive about the potential difficulties in [AiCating this ts fuku yea.
LINGEN DAVIES CANCER FUND CIO TRUSTEES, REPORT (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2022 Fundralslng Standards 1rrf0m0n CA162A The charity receivès the maj¢ty of funds from the putlK. la) The tharty undertake5 fvnd-r8i5ing thcwh Jjr inlemal reslS and staff team. We do not o)mmission a professional fvnd-raisarlcommerual parb(xpator for these: Ibl The charity is gIStered the FuThJraising Regulalor and atxdes by good practices 5tsndards set out by the regulator. The charity's internal Guide to Fundraising relects these and gNes inforrnation to staff and volunt68rs about how lo fvnd¥8iso18gally. ethically and wrthin gr practice staThlartls". cl The charity monttors fund4aisbng thibes via the Twstee t(rd' (dl The ch8Tty received no ccnF4aints aboLrt a(knit for the purpose of fundraising during thi5 year, lel The ch8tity has adopted winThptes of GDPR logiation a150 has Safeguaing FJliues to protecl the data ol vulnerable peoplè and other members ofthe wbiic from.. lil UnreasonatA8 intrus)n on a peOn5' Ixivacy" lill Unreasonable stent approa(es for the purkw of s(Ai(iliro or othemse prrywring money or other propety of the charily, (iiil Plaung undue pressure on a to give money (x other Fwrty. Achlovements and porfornnce Like many tharits"es, we have experierwl a tange of challenges presented by the Covid-19 pandemic. However, we made some bold decisions during the pandemic. afKt maintained a fijll complemènt of staff, who spent their lirne exploring new avenues of fundraising, maintaining ntact wtth (xjr volunteers. and planniNJ for batter bmes ahead. As a resu of thÈs. our fundraigng has hrt the ground running as we come of the imn)ediate irvpad of the p8nd8mic. We are extremely proud to have had a recor&breaknng year for income gèneration in 2021122, raising over £1 million for the first time in thè charity's hist. This a tèstament to the hard work of OUT stsff tèam and to the commitment and generosity of our supp)rters througlKMJt the community. While we are very pleased with this SLWSS, we a mindfvl of current lo(al and global challenges. and we must now V•vrk to m8ko this level of income sustainable,. we ¢annot take fi foT 9rant8d. We are plèased that the extension to the din rooms in the Lingen DaaS Centre has been u)mpl8ted. and these rooms are now in use. These rooms increase capauty for appoinbnents. give Sp for telemedIne ttjnsultab'ons and therefore enable the clini1 team to resw)rKI lo changes In patient number5 and devdopments in treatment options lo ènsure the best FX)SSttAe outc( for patients. Thi5 prgect aso enabl u5 to convert 8nothgr room in the Lingen Davies Ceftt into a small fundraisirKJ offi. wing us greater presence in the space and providing additional working spac8 for the staff team. The CT Scannei, also beiTrJ fvnded from our Last appeal. is on sile at thè knNJen Davies Centre and will be fully operational by laté July 2022. This wll improve thè acojracy of treatment 8ning. 8naNing staff to better protect patients from the harmfijl èffects of radiotherapy on norrnal b"SSLFe. Our LweLrfe project is growng. for the first time in Ihe charity's history we have been asked to act as a delivery partner for an NHS project. The Core20+ project is fvnded by the NHS aryj we are woMng tn partnership with NHS Shropshire. Telford & Wrekin. as well as Ial tharity Qube. to deltver this exciting pr(4ect. This is th8 result of some long-temi, strategic work dÈv81(¥)Trng our exiemal relationships and uedibilty in the local Br. and we hope this wrfl be the fir of many agreements of this nature. We are exrit9d to be expanding our woE1( bèyond our traditional fundraising fu major appeals, but still have fundraising at the heart of what we do. We ar8 weil aware of the pressures faung our health services and on peoples, finances and wl1 rnaintain dose links wtth I(1 NHS and local aulhcty bodies to ensuTr our plans complernent wider strat8gies and contribLrte to s better Èxperience for peOe living th cancer tn our region.
LINGEN DAVIES CANCER FUND CIO
TRUSTEES. REPORT {CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2022
Our CT Scanner and Clinic RoornsApp8al- £812.830
We were very proud to complete our apFWt for mapr proje(Js this year the extension to the dinic rooms in the
Lingan Davies Cent. and a new CT ScaM8r for the rddiothèrapy department This total indudès the purchase of
three Ixxjches for use in the dinic rcoms. The IPIe110n of this appeal was delayed by 12 months due to the
impaci ol the Covid-19 pandemic, bLrt we are pleased to see these projécts comp and ttr dIti.0nal Services
now available for the people of our KIn.
Kick Canc8r- £YO.fKKI
Continuing ujr felationship with Shrewsbury T
LINGEN DAVIES CANCER FUND CIO TRUSTEES. REPORT (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2022 RadarKeys- £633 We have be8n working in pathership North Shropshire PrFmwy Caro Netsw)rk to rAovide radar keys to people INing with cancer. A radar key giv8s asS lo putAic dIsaed loilÈts. and these arè often requir by people who's cancer. or e effeds of their treatrnent. means th they need to access a toilet quickly, or requi18 space and facilities to deal with thin95 sud) as stomas. when Ihey are away from homa. Patients arp offered the keys via their cancer care coordinator in their GP practice. as part of their usual appointrnents. WE have already had some very positive feedback on the project. from pÈorAe deIng irwsed feelings of confidence and freedom at b&ing able lo go oul knowÈng they will be able to accw a tollet il ttw need one. We aro in contact with all other PCN'S in the region and intend to rc4e this project out across the area in the coming year. As wéll as providing funds for extemal projects. we have expanded wr health promotion w)rk vrith th8 LiveLife Projecl. We have attended pU1C events, wrjrkplaces and h¢gh streets gmng infonnation about the earfy Signs and symptorns of (ancer, and encouragiTrJ peOe to seek help rf Ihey are t)rrIed atK)ut chan9es In their body. We have gNèn ¢yJt many hurKlreds of free sunscreen sachets, gNen lalks to uNnmunty groups and have rec8nUy opened a consultatN)n h)okirYJ at gaps in social arKJ emlional SUWM)rt that we may be able to fill in the future. We are also working with Powys Teaching He8tth B03td to lry and develop a communrty-based suptx)rt project for people living with cancer in Mid waS. There are enormous opwthnthes in this arèa of WC and we are very eX(tad lor its future. Thanks Th8 Trustees wish to exwess th&r thanks lo th8 peoFle of Shropshire, reIfd & Wrekin. and Mid Wales. vthose supp)rt forthe charity has en exceptiOr7 once again. We are living in very chaIngIng tim8s, and we cYJntiTrue to be amazed by th& wllingnwss of our supporters to give Iheir time. money and gocmlwill to support us, and people affected by cancer in our region. We would also like to thank the stsff team and ttJThJrabJlate them on &Xceptial year of fundraising snd development in the charity. We also thank our patron, Lady Jane Hebef-Pwcy. fty her SUPFQrt arml geity. None of the charity's work vJkl be with(xrt the commitment of Ihe staff and volunteers, and the truste88 are very gratèful for thEs. Streglc Developm•nts Fdlwng a development phase in 2021 aTrJ earfy 2022. our new Strategic Plan will published in Summer 2022. This will be 8¢companied by intemal okwational plans and KPI'S giving the staff team and trustees a dear vision for the fLlture of the charity. Our strategic themès remain untharvJed, and we o)ntinue to frJ$ our resour on: ImprovÉng cancer prevention and earfy diagnosis rates in (Kjr (a)Mrn Excellent treaknent and services lo(%ny Sutwrting peoKAe to live well. with and beyorxl r2ncer We are making plans for fUrIng arml delivering 1Th4ects that Uy)Iritrte to all of these strategic ttw)7es. Flnancial r•Yiew The attached Statem8nt of FinarKial Acvrbes kn the pVJ from 1 April 2021 to 31 March 2022 refieGts the incoming rasources. resoufces expended and the overall movement in tsJnd5 for thg year. Our community fvndraising has ¢yyth"nued lo impacted by the Covid-19 p8nd8mic, but due to the diversifi¢ation of our activities. other areas of fundraising have 9allY improved and thfOre we have had a very strong year. We would like to thank the trusls who have suppyted u5 Ihis year. The Lady Fwestèr Trust. The Wenlock Fo$ter Charitable Tnjst, The Westcroft Trust. The Lord Levethvlme Cha¥itatde Trust. The Wingheld Trust and the Wynn Foundatson. G hay6 dlW wmo Fnwous WPWt from k1 businesses aTrJ Wle th1(9hout our community. In particular, we thanks Tdford Plaza Ltd. who have m* a Signifnt donati¢)n to fund the purchase of the Lingen Dawes van, which wll be in use by mi&2022.
LINGEN DAVIES CANCER FUND CIO TRUSTEES, REPORT (CONTINUED) FOR THE YEAR ENDED 31 AIARCH 2022 Reserves Wthin Trstricted fijnds as at 31 March 2022 is £52.449 whith repre6wts ex(ss fijnds: this will be allocated to pay for a scalp cooEing machine currenty in discJJssions wtth ShWStroJry and Telfwl Hosal CarKer SeThices at the Lingen Davies Centre. and thè remain(ter to Ihg ican woiect The Trustees aim to keep t200,0(M) (2021". £2W.0001 in designa reserves. to cover running costs In the event of a 8eriou5 (2sh flow problem or other mai)r unforesegn expense5. This policy has provided grnat reassurance during pandnIC all0v us lo make the dec4&0n to continue operating a lull staff team. As our income has been stronger Ihan expect during thi5 peri wr designated reserves havtr not been utilised durirwJ thkg year. The Trustees liaise with ShVbry and Telford HOS1 NHS Trust aThJ other organisations that prwde t>ncer serwces locally to tdentify proiails on lo spend their fvnds. The Truste8$ are of opiiion that tho rasrCeS they relain and anlic4pate receNitwJ in the fire will them to meet effectively Ihe current and fijture aims for Ihe rdief of oncer pabents in Shropshire. Telft)rd and Wrekin and Mid Was. The unresth¢ted free reserves of th9 ¢h8nty as at 31 M8r¢ 2022 were £Il.6T[ {2021: £549,158}. ThSs indudes legacy donation of £357.643 that we intend to use primarily to supwri projects in Powys. as this 15 whère the legalor lived. However, this was not a condition frr)m Ihe donor and the funds maybe spent 8lsewhere if a suitab project is not èstablished in the ¢x)ming 12 months. The capital commttm8nts 11 met by and fiJbJre furmjraksing (as per Th)te 221 and are therefor8 exduded from th8 free reserves calwlation. Invèstments Thè Trustees are aulhorised to invest the assèts cl the in 7thatever way they betkve to Le in th& besl interests of the charity and ts obiectsve& In light of the current èrxjnomic sittjabon. the Trustees have (xx)sKlered the ryK)st appropriate poliry for investing funds and have agreed that retaining furKls in cash investrwts best meet their r8quirements lo generate income whilst maintaining capital for the long term. Risk management The TnJstees have èxamined the may)r 5tral8gic. bJsin8ss arKI operat risks whth the charity f8ces. The Chief Executive Officer reports regularfy to trustees on matters of risk manage[rL The Audit and Risk Committee meets regul8rty to review risks and bad( k) all Irustees to re[71[nd the steps that sh{Md be taken to fflinimkse these risks, wherever possible. The Trustees have implemented a Scheme of ddegatK)n. responsibilty to Ihe Chief Ex8(xJtive Officer for operattonal risks. The Chief Executive Offiw aÈiends Audit and fvsk Commiltee meeting5 and elateS serious risks lo the Chair ofTrustees as appropriate.
LINGEN DAVIES CANCER FUND CIO TRUSTEES. REPORT (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2022 Plans forfuture pe1$ We are working wth partners in Shrewsbury and Telford H¢wtWs TrusL NHS Shropshire, Telford and Wrekin, and PS Te8thing Health Board. to devdop rtr8w proieds for the (MIng year. Thi5 wll be a combination of our traditional fvndraising and giving of grants Eo enhance Tr1 oan(w s8Mces. and also wothiThJ in partnership with other tJdie5 to deliver projeds oursdve We are ox(ited to see the Lingen Davies van ffi the njad, alTrg us to get out tnlo our (x>mmunitiÈs mor8 easAy and with a more prof8ssional appeararKe. We have agrewj to raise ndS to suppcwt ican fw a fvrther two years. following the successfvl pilot of Ihis proiÈcL ican is being developed and evaluat1 kn partnèrship University Centre Shrewsbury. and we are very pleased to see this proiect devejoyng. We are making plans for anolher excellent year of lurmknising èvents. aThJ kng to grow our legacy fundraistng, rKI inuease applications to trusts arKI foundati(x)s. Our Chair of Trustees, Mandy Thom MBE DL. is st8ppirwJ down al Ihe end of her very suixwfvl t8mi of officè, in December 2022 and are in the process of rewrfing a Chair to cwtinue Mandls excdlent Irk in leading the boafd since 2016. structure. governan and management The Lingen Davies Cancer Fund, Fundraising Offi¢x, Hamar Certre, Royal Shrewsbury Hospital. Mytton 08k Road, Shrewsbury. SY3 8XQ is registered wth the Charity CommissK)nets. num{ 1160922. as a charitable incorporaled organisation and the Charity was entered on Chaty Commission Register on 16 March 2015. The Charity currenlly has 13 twstees. The m8muM nunknr of trustees 15 15 and there must be a minimum of 5. Truslees are appointed for a tem) of 5 years and new trustees are appointed with regards to skills, knoedge and experien needed for the effeclive administration of Ihe chanty. New Irustees go through an iFxluction procw to ensure they are fvlty InfOr¥ll aboul the charity and rfs aims an(1 i)jedives. The Board ofTrustees meets quarterfy txrt Ilwe are abo varwjus ccrfnmittees as frA10.. Finance FurKJraising Support Audrt and Risk Grants and Projects HR The committees rneet in between tnjstee mee11rs. a5 requirwl. th8 Chair of eath committ reports back lo truslee meetings and makes recommermjations to the Board. The Charity works dosely with Shrew5bury Telforrl Hospilal Tnjst and their Director of Corporate Govemance regularty rew)rts on hospital tnjst Matte to the Board. In addibon. staff appointed prior to 1st April 2020 are joinuy employed by 1he Charity and Tnjst. The pay and r9mun8rati()n for key management personnel are guideil by NHS pay scales. Since 1st April 2020, new staff joining the Charity have been empknyed directy by LiThJen Davies Cancer Fund and are not subject to NHS temis and dbOnS. However. we are (x)mmi1 to treabng our staff well. providing good employee beneffts and ensuring a posibve workiThJ env1rcfflnt for all. An exterrtal HR consultant is engaged to support the managemenl team in ensuri apwwate HR pdicEs and proureS are in pla and to h81p manage any HR issues as they arise. The day to day responsibility for njnning the charity is degated to the Chièf Exeujtive Officer, Naomi AU(in. Naomi retumed from Fnatemrty leave in earty May 2021, havTrng been covered by intèrim Stuart Reynolds in her absence. Naomi is supported in the managetT*llt team by Operations Manager Louise Dawson. and H88d of Fundratsing He18n Knight. Relevanl tasks are delegateil to the managemertt team and other members of staff. The chaS Banker5 and Audrttys are detailed on the Legal 8fbd Administrative page at the t¥eginnin9 of the Financial Statements.
LINGEN DAVIES CANCER FUND CIO TRUSTEES. REPORT (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2022 Roference and Administrati D•talls The Trusl88s, who serveil duriThJ the year WEre: AJ Thom MBE DL {chaiMnI MrA Killey (Vice Chairman) Mrs C H Thomas ([reasUr} Dr N N Srihari Dr G Eatough Mr D Jackson Mrs A Kenny Mrs F K HLttcheson Mr T Cooper Mrc Leak8 Mrs J L B88v8r Mrs VA Edwarrls DrJ RJohnson MBE Patron The HonOurae Lady Heber*e New trustees are elected by the existFng Board. The Chair of Trustees wrfl (XTrTTre to the end of her very successfvl term ol office at the end of 2022. and an$ are in aCe to rec¥urt a rew Chair to ce hèr and continue her excellent leadership of the board. The Trustees, rep)rt was approved by the Board ofTnJstees. AJ Thom MBE DL IChairm8nl Chaim)an
LINGEN DAVIES CANCER FUND CIO STATEMENT OF TRUSTEES. RESPONSIBIUTIES FOR THE YEAR ENDED 31 MARCH 2022 The Trustees are responsible pparIng the Trustees, ReF¥Xt finarKaal statements in Cordsnee With applicable law ar United Ktrngdom Ac(x)unting StarK13rds {United Kingdom Generally Accepted A¢xx)unting Prdcticel. The law applicate lo charities in England and Wales wuires the Trustees lo prepare firsancial statements for each financial year which give a twe and fair wew of the slate of affairs of Ihe charity and of the incoming sourceS and apFlication of sOurceS of the tharity for Ihat year. In preparing th8se fjn8ntxal Staternen the Tnjstees are rw4uir•J lo.. - select suitable accounting pdiaes and then apY t (xjnyslenty. - observe the methcYs an(1 pnnoes in the chatieS SORP: - mak8 judgements and estimates that ar& rèasonatAe - state whether appliCae accounting starthrds have been followed. subject to any maten.al departures disdosod and explained in the finarrial statements- and - prepare the finanaal statements on the gjing concem b9 unths it is inappropriate lo presume that the (arity will <X)ntine in operat. The Trustees are responSie fry keeping suffiaent aco)unting records that disdose wth reasonable acwracy at any time the financial pOSttK of the chartty and enatAe them to ensure that the finawal statements comply with the Charities Act 2011, the Charity IAccount5 and Reports) Regulalions 2008 and the prowsions of the trust deed. They are also responsible for safeguarding the assets of the charity aThJ for laksThJ reasonable steps for the pieventM)n and detecbon of fraud and other irwularilies.
LINGEN DAVIES CANCER FUND CIO INDEPENDENT AUDITOR'S REPORT TO THE TRUSTEES OF UNGEN DAVIES CANCER FUND CIO Opinlon We have audited the finanaal statements of Lingen Dawes caer Fund CIO (the 'thaiitll for the year ended 31 March 2022 which comprise the statement of finanTral a¢tivtbes. the b8lanr£ sheeL the ststement of cash flows and Th)les lo Ihe financial statements, induding s¥Jnificant ac(wntir¥J Oiues. The finanual porting framework that has been appli8d in Iheir pParation is applible law and United IfjFyJom Accounting Standards, including Financial Repo.ng Stsndard 102 The Finanal Reporting Standard applicable in the UK and Republic of Irgland (uni Kingdom Generally Aepted Accounting Pr¥b"cel. In our opinion, the finanual statements: give 8 true and fair view of the state of Ihe thariVs aTrdirs as at 31 Marth 2022 and of ils inryxning resources and application of resour. for the then ended: have b88n prowly prepare(l in actr)rdan wilh Uniw Kingdcffj Gerwalty Actspted Accounting Practice., and hav8 been prepargj acuxOance with the Th]uirements of the ChaiitiesA¢t 2011. 8asls for opinion We conducteil our audit in accordance Intemats'onal Standards (x) Audng (UK) IISAS IUKII and appliGgbla law. Our responsibilities those staThJards are fvFther described in Auditorfs respyjsiknlth.es for the audit of the financial statements section of our pOrt. We are irKlependent of the chartty in accordance with the ethical requirements that are relevant to our audtt of the financ4al stements in the UK. induding the FRC'S Ethical Standard, and we have lulfilted our other ethiGal responsibilFtses in aCt(dan these requifements. We believe that the audit eene8 wè have obtained is suffi(ient and appropnate to prtivide a basis our opinion. Conclusions relating to going concern In auditing the financial statements, we have widuded that the Trusts' u$8 of tho wrBJ ¢1M basis of aw)untiro in the preparation of Ihe financial slatements is appropriate. Based on the %bY)rk wè have pthTrn. have Ev)t ¥Jentified any matsiia urKertainlies relattrwJ to events or conditions that, individualty cdtecbvety. may $1 significant doubt the chantys aknlity to )ntinu8 8s a going for a period of at least twelve months from vthen the financsal stalemenls are atrthorised for issue. Our responsibilities and the rèSw)nsibdii of the Tnjstees wilh respect to wng concem are described in the relevant sections of this reporL Other infomiation The other infomiation comprises the Informa induded in the annual rewmt other than the finan¢ial statements and our audf(orfs )rt th¢r6on. The Tnjstees are responsNI e for the other inforrllation contained wiihin the annual reporL Our opiTrion on the finanaal StatentS not (x)veT the olher infomation and we do r)ot èxpress any form of aSsrare conclusion th8r80n. Our resF¥)nssbilty is lo r8ad Ihe other inforn)ation and. in doing so. consider whelher the other information is materially inconsistent wth thè finanual statements or our knOedge obtained the course of the audit. or otheise appeats tr) materidly misstated. 11 we identify suth matefi81 intx)nsistenci&s or apparent matèrial misstatements, we a required to detem)ine whether this gives rise to a material misstslefflenl in the finanryal statements themsefves. If. based on the work we have perform&J, we ¢ondude that there 15 a material misststemenl of this other infom)ation. we are required to re that fa We have nothing to report in this regarf. Matt•rs ¢)n which we are requir lo rnport by excepti We have nothing lo re[ in r8spect of the fdloirwJ matters in relalion to whid) tho Charitses {Accounts and Report51 Regulations 2QM18 require us to retM*t to you if, in our opinion". the infom)ation given in ts finandal statements is Ir¥s1$tnI in any material respect with the Trustees. reporL" or sufficient 8(xx)unttng records have not been kopt: or the financial slatements are not in agreementwth the accoLtntiThJ rewrds; or we have not re¢eiv8d all the informatK)n eW8nations we )Ul for our audiL 10-
LINGEN DAVIES CANCER FUND CIO INDEPENDENT AUDITOR'S REPORT (CONTINUED) TO THE TRUSTEES OF LINGEN DAVIES CANCER FUND CIO Responsib51itles of Thistees As explained more fully in the staieffnt of Trustees. $1sIbIles. Trustees are responsible for the preparation of the financial statements and for being $8ti5fied th81 they gTve a true and fair vw. and for such intemal control 85 the Trustees deternine is necessary to enab th8 pr8paratK)n of finaficial statements that are free from material missialemenL whether due to fraud or error. In preparirrfj thè financial statements, the Trustees are responsible for assessing the charrty's abil to conlinue as a g(Mng 1x)nrn. disdosing, as applicable, matters related to going concem and using the wing (xjncem basis of KIting unless the Trustees either intend to caas8 operabons. or havè no reatislic 8lternatsve but to do so. Auditorfs r•sponslbllltlès for th¢ •udit ot the financial statements We have been aPtrted as auditor urKler seclion 145 of the Charibes Att 2011 and report in aaft with the Act and relevant regulati)ns made or having effect thereurmlef. Our objectives are to obtain reaSonae asSlTrr about ¥rtth thè finanwl ststements as a whole are free from material misstatement, Tr•thether duè to haud or error, and to issue an auditorfs repct that indudes OUT opTrnion. Reasonable assuran is a high level of awjtsnce but is not a guarantee that an audit conduth in acctsrdaneè with ISAS IUKI wll always detect a material misstatem8nt when it Misslat8m8nts can arise from fraud or error and are conSided material rf. individualfy or in the aggregate, they (JId reasonably be expect8d lo influence the economi¢ deon$ of users tsken on the basis of these finanual slatements. The extent to whith proc8dures are capat4e of detecliNJ trregularilies. fraLKI. i8 detailed beh)w. we identified the faws and regul8b.ons appficatrAe to the Charity Ihrough discussions with th8 Trustees and other Manage1, and from our knoedge and eXrien1> of the Charrty seclw, we focusad on sp8cific18ws and regul81ion5 which we consider&J may have a direct material effec on the finanoal slalemenls or the operations of the charity. induding thè Charity Act 2011 and iaxation and data protection., we ensured th8t th8 manayemeffl team have the appropriatè competence. capabiltbes aThJ skills to identsfy or recognise noTr o)mFliance th applicable laws and regulati(S., and identifjeLI laws and regulations We communi(2ted wÈthin audil tsam regulady and the team remained alert to irsstances of non-compliance thff>ughotrt the aud We assessed the susceptibility of the financi81 statements to material mi&8tatement, induding obtaining an undeTstsrKling of hLAV fraud rnht ctcur. by: making enquiries of management as to where th8y lderj there was suscepts'bility to fraud, their knowledge of actual. suspect8d. alleged fraLhd: and considering the intemal contrds in place to mitigate risks of fraud and norHX)mpliance with laws and regul8tions. To address the risk of fraud through managÈnwt bias aThY oveTride of controls. we.. p8rformed analytic21 prcKedures to identify any unusud or un8xp*d relationships,. testjoumal entries to identify unusual transaclions., assess whether judgements and assurnpknns made in detemiinirKJ the a¢xJunb"ng estimates sel cth we indilive of y)tentHI bias- and investigatèd the ratiale behind sFJniknt or unusual transadions. 11
LINGEN DAVIES CANCER FUND CIO INDEPENDENT AUDITOR'S REPORT (CONTINUED) TO THE TRUSTEES OF LINGEN DAVIES CANCER FUND CIO In resporw to the llsk of irregularibes and n(18n( with la aTrJ regulati(, W8 designed proce(lur8s wthich induded, bLSt were not limited to: agreeing finan(xal statamenl dk8dosures to underfwng suptx>rting tkxxJMenlatic', reading the minutès of maatings oflhose charged governance: and enquiring of management as to actual and potenliJ libgation and daim. There arè inhérent limitatwms in Jr audit prowlures &sbj above. The more removed that laws and regulations are from financial tr8nsacbons. thè lèss likdy it is thal we would become aware of non- compliance. Auditing stsndards also limit the audit pro(xdus required to Hlentify n0rpcomp1iare wth 18ws and regulations to erouiry of the trustees and other man899mt 3nd the inspection of Tegulatory an(1 legal correspond8n¢, if any. A fvrthar description of our respsIbIl[lieS 15 awdilalAe on the Financial Rep)rting c(7.S wgbsttè aL htlps'.11 www.fro.org.uklaudrtorsresponssbilities. This description forrns part of ¢MJT auditorfs repct. Oth•r matters This report is made scAely to the (x)mPaS members. as a txxty. in accordance wtth section 391 of the Companies Act 2014. Our audit work has been undertaken so that W mvJht stste lo the wmpany's membèrs those matters we are requireil to state to them in an auditorfs report and for no other pur. To the fullest extent Permitted by law, we do not 8ce6pt or 8ssum8 r8spofkgibilty to anyone other than the o)mpany and the company's m8mbeT5 85 body, for our audit work, for thkg report, or for the wnions we have formed. Cagr¥¥yn Jones Chartered Accountants Statutory Auditor Emstrey House Shrewsbury Business Pa Shrewsbury SY2 6LG I{ Lo Caervtyn Jones is elwJit4e for appointrment as auditor of the charity by wrtue of its gligibdty for appointment as 8udilor of a company Ufthr sethon 1212 of the CompaniesAct 20(K. 12-
LINGEN DAVIES CANCER FUND CIO STATEMENT OF FINANCIAL ACTMTIES INCLUDING INCOME AND EXPENDITURE ACCOUNT FOR THE YEAR ENDED 31 MARCH 2022 Totsl Unrestrleted R•strlcted funds fvnds 2021 2021 Total funds 2022 funds 2022 2022 2021 In tsme from: Donations and lega(>ès Gharitable activities Other tradin9 activities Investmènts 286.077 598.749 44.636 144,341 1.232 884.826 389,139 44,636 145.090 2.520 272.226 661,365 749 1,288 48,586 48.586 8,936 7.927 T<rtal incom8 288,114 788,958 1.077.072 397.1 321,821 718,887 Ex iture o Raising funds 28.OW2 216.940 245.022 23.860 148.763 172.623 Chartiable activÉbes 133.897 812.830 946.727 1.658 158,rro 355.428 Total exp•ndltUTe 161.979 1.029,no 1.191.749 220.518 307,533 528.051 Gross transfer5 bth*n furKIs Net incomèl(expenditurn) for the yearl Net movement In funts (29.8451 29,845 126.135 1240.8121 1114.6771 146.703 44,133 I.836 Fund balarKes at 1 A[1 2021 783.¥24 337.W38 1.121,822 637,221 293,765 930,986 Fund lanCeS at 31 March 2022 910,059 97,086 1.CK17.14S 783.924 337,898 1.121.822 The ststament of finanaal acli¥itss indudes all gains and k)sses re¢(yJnised in Ihe year. l InMe and expendÉiure derive from c4Jnlinuing aclivibtss. 13-
LINGEN DAVIES CANCER FUND CIO BALANCE SHEEr ASAT31 MARCH 2022 2022 2021 Fixed ass•ts Int8ngible assets Tangible assets 13 14 1(X).382 108,382 3.666 Curr•nt assets Stocks Debtr)rs Cash at bank and in h¥nd 15 16 638 235.638 1.520.814 2,219 39,458 881,581 1.757.0 1283,258 Credit¢rs: amounts falllng due within one year 17 (858.327) 1165.1021 Net culnt assets 898.763 1.118.156 Total assets less current Ilabllltles 1.007.145 1.121,822 Income funds Reslricled funds Uniestricted funds Designated funds Gèneral unrestricie(t funds 97.086 337.898 19 200.000 583.924 710.059 910.059 783,924 1.007.145 1.121,822 The finanaal ststements were approvÈd by the Trustee5 1)n.. Mr A J Thom MBE DL (Chairman) Trustee 14_
LINGEN DAVIES CANCER FUND CIO STATEMENT OF CASH FLOWS FOR THE YEAR ENDED 31 MARCH 2022 2022 2021 Cash flows from opèrating activi1$ Cash generated from 0[tionS 746.833 29.279 Investing activities Purchase ol intangible assets Purchase of tangible fixed assets Investment income Ceived {12.() 198,120) 2.520 14,1511 8,936 Net cash Ius8d Inygenerated from tnv•sting activities (107.6C(J) 4.785 Net cash used in financing activltl•s Net increase in cash and cash •qulv*nts 639.233 34.064 Cash and cash equivaents at beginnirvj of year 881.581 847.517 Cash and ¢a$h equi¥alents at end of year 1,520.814 881.581 15-
LINGEN DAVIES CANCER FUND CIO NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2022 A¢eountlng policies Charlty Infomiallon Lingen Davies Canr Fund CIO is a (arrtae incorForatwJ ¢xganisat)n. register&1 in England and Wales. 1.1 A¢¢ountlng conventloD The financial stst8rnents have been prep8re(l in ac0)rd8 the charitys goveming document, the Charities Act 2011 8nd "Accounting arwj ReportirKJ by Chaiibgs.. Stat8ment of Reo)mrnend8d Prackn applicable to ch8ribe$ preparing their a(x£wnts in accordance with the Financial Reporting Stsndard applicable in the UK and Republ of Iland IFRS 1021" las amended for nting perityjs commencing from 1 January 20191. The carity i8 8 Publi¢ Benefit Enbty as defi[d by FRS 102. The accounts are prepared in stertiThJ. whith is furKkn)al ojrrency of the dwity. Monelary amounts . these fin8n(xal statements a rouNJ8¢J to the nearest £. The 8rawnts have been prepar•d on the h1$knl cost convention. The prin(ipo1 accoLsnting Fdicios adopted are Sel out bek. 1.2 Golng concern At the time of approving the financial statements, the Trustees have a reasonable expectstion thal the charity h8s adequale resoLsrces to )ntinue in Operation existen¢x f(K the loreseeable future. Thus the Tnjstees ¢ts"nu& to alopt the going o)rwn bas of ac(xyJnting in prep3rirtsJ Ihe finanoal ststelrnts. 1.3 Charftable lunds Unrestr¥cted funds are availat4e for Ltse at the discrelK>n of the Tnjstees in furtherance of Iheir charitable objectives unless the funds have been dgsKJnat8d for other PLtrposes. UnStn"cIed fuThJs are donan$ and other red for the gewal thiects ofthe tharity. Restricted funds are subj'ect to speufic {a)ndib.S by donors as to how they may be uwl. PUryK)ses arKI uses of the re5tn"¢tod fvrKls are set Ixrt sn the nirtes to the Slatents. 1A In¢ome Irme 15 renISed vthèn the chaEity is18gaty ènliuèd to it aft8r any perfomiance ¢))nditions have been me( the amounts can be me8surwt reliably. and tt 15 probatA8 that incomè 11 bè r1ved. Cash dcfflalions are recc¥Jnis&J on recpl Other donakns are reniSed the chartty has bèen notffi8d of the donation, unless perfOrnr lditiOnS r8quir8 defgrral of lh8 8m(x]nt. In(x)Ine tsx re(x)verable in r8lab.on to donatity)s r1¥8(1 urKier GrfiAM1 or deeds of covenant is rec(yJnis&1 at the time of the donation. Legaues a re(wnised on re(rpt or otherwse rf the tharity has been notified of an impending distribution, the arnounl ss known. arvj receipt is exlell. If the amount is not knovm, the legacy is treated as a contingent asset Assets given for use by the charsty are recrynis&J wtRn T¥able. Income from governMenl arxl other grants. vthether'capitaf grants or'revenue. grants, is recognised when the charity ha5 entiuement lo the fvnds. any perfn8c ¢y)rKlitÈons attathed lo the grant have been met. it Is probable that the income wll be receNed and the arrUt be measured rdiabty. Tumover is Measu at the fair value of the consideralion receNed or receivable 8nd represents amounts receivable for 9(S and services in the rna5 course of trojslrS3. net of disownts. VAT and other sales related tsxes. 16-
LINGEN DAVIES CANCER FUND CIO NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2022 Accountlng policse Icontlnuedl 1.5 Expenditur# Expenditure is recryJnised Ihere is a al or construc¥e oblwjation to transfèr aconomic benefft to a third party, it IS Probable that a transfew of economK b8nÈfils wll be rwuired in sethemenL and the amount of the oblKJation bè measured reliabty. Expgnditure is dasSid by aclM"ty. The costs of earh athity are made up of the totsl of direct cos15 and shared Sts. indudsng supwrt o)sts irwdved in LIndertakY eath actNity. Direct costs attributable to a single activity are allocated dir9Gty lo thal activtty. Shared costs whith contribute to more than one activty and support costs vA)ich are not attributable to a single activty are apporliorhed between thostr activthes on a basis eonsistent with the use of resources. Central staff (x)sts are allocated on the basis of time spent, and depreciatson charges are albcated on the tM)rtsM of the a&%et's use. Direct ChaTitable EndItsJre The objects of Ihg d)arity are lo rai$8 funds to F¥ovidg grants to SUPF4Yt thè of cancer h$8lth care professionals lor the treatment of cancer patients in shropshi. Telford and Wrekin and Mid Wales, the provision of services dire[ to cancer pab.ents raising awarèn ol cancer prevention in the area. Any èxpenditure spe¢ffi(2lly to achieve th otyects is indijded in direct charrt8bl8 expenditure. Governance eosts Administrab"on expenses of the charity rel8t8 to the o)sts of runniThJ the charity. such as insurance. accountancy fees and o)sts of slxtuiory coml8r. and wdude any Ixksts vA)ich canrt be spgcÈfically attribul8d to anolher expenditure dassÈft(ztity). 1.6 Intangible fix assets othèr than goodwill Intangible assets acquired separately from a business are recognised 8t (x)sl and are subsequentty m¢8sured al cost less aLMlat amortisalion arKI amlIaEed impgim)ènt losses. Intsngible assets acquired orb busll)ess combinations are recognised separately from gcthfjll 81 the acquisition dale where it is prObae that lh& Èxpected fljre e(x>nomic benefits that are attributable to the asset will flow to the entity and the fair value of the asset (an be measured reliably," the intangible asset arises from contracttjal olher leg rhts. and the intangible 8&%8t is separalAe froffl the entity. Amortisation is re(wnised so as to 7Kite off the cost or WdIuat of assels tess th86r reskjual values over their useful li$ on the fdk)wing bases". Website 33.33% PA. on cost 1.7 Tanglbl• fixed assets TangitAe fixed assets 8fE intbally measure(l at u)st arwj SLt6equenity measurgj at cost or valuation, rt of deprKiation and any ifflparmenl losses. Depreciab"on is recognised so as to write off the CKtst or ValUatic of assels le5$ thalr residual values over their Useful lives on the follow7ng bases: Equipment Soknre Motor vehides 20% p.a on cost 33.33% p.a on cost 25% p.a on c05t The gain or loss arising on the d1 of an awt is determined #s the drfference between the sale proceeds ar the carrying value of the a&%et. and i8 recx)gnise(t in Ihe StateTrt offinawal adiwties. 17-
LINGEN DAVIES CANCER FUND CIO NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2022 Accounting policies Icontlnuedl 1.8 Impairnwnt of flxed assets At each repofbng end date, the charity reviews the carying amnts of its tangible and intangible assets to deterrnine wheth8r there is any iTrJication that those assets havè suffered an impairment loss. W any such indication exists, the Feeoverable amount of Ihe asset ts estimated in order to detemine the extent of the impairment loss (rf any). 1.9 Stocks Stod(s are ststsd al the lower of cost and eStirnat selling pri(x lè&8 cosls lo comete and sell. Cost compTises direct materials and. vthere 8NAI(xe. direct labwr costs and tlx>se ovetheads that have been Sncurred in bringing the stocs to their pr8s8nt location and (ndItion. Item5 hgld for disln"bution at no or n¢Mninal consideration are measured al the lower of re[Aat cost and cost Ngt réalisable value is the estimated selliru prth lass all estimated c3)s13 of c(81%n and cosis to be incurred In marketing. selling and distribution. 1.10 C•$h and equlvalents Cash and cash equivalents indude $h in hand. deposits held al with banks and olher short4erm IiquKI invostsnents wtth original maluTitses of three KthS or less. 1.11 Employee beneffts The cost of 8ny unus8d tK)fiday entruement is Tecognised in Ihe perJJ in whbth the emFAoyee'$ seryic8s ara received. Tamiination nefftS are recogni8ed imrnediatety as an ex[Se when the tharity is demonstrably committed to tem)in*e th8 ampk)ymant of an employee orlo pThid9 teminatK)n beneffts. 1.12 Retlr•m•nt nefits Payments to defin1 CDntrIbutK relirement tefft schemes are drged as an ewse as they fall due. 18-
LINGEN DAVIES CANCER FUND CIO NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2022 Donations and legacies unStricted Re5tTiCted Total Unrestricted Restricted fijnds funds Total 2022 2021 2021 2021 DOnatnS and gifts Legaues CeiVable Grants re¢eivaNe 117.394 400. 164.315 517.398 169.315 198.113 13,854 374,298 244.9 2.724 24.593 258,763 377.022 25.580 193.745 286.on 598.749 884,826 389,139 272.226 661,365 The amounts shovm alx)ve indude unpaid1gg$ Wh due to the time and Cmplety taken for legacies to crystallise, this income may not be re(%NwJ wthin 12 Wth"n debtors at the year end unpaid legaaes amount tts £157,711 12021.. £370.685). Grants re¢eivable for core activities CJRS Grant ShTopshirè Councj Other Grants 1.293 5.000 18,300 2.280 5,000 18.300 193.745 197.TT9 193.745 198.113 24,593 25,580 Charttable activilieg R•strlcted fvnds 2022 2021 LNeLrfe 44,636 Other tradlng aCtlvltl•s Total Restricted funds nds funds 2022 2022 2022 2021 Fundraising events erchandise 749 123,271 21.070 124,020 21,070 21,641 26,945 749 144.341 145.090 48.586 19-
LINGEN DAVIES CANCER FUND CIO NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2022 Invostsnents Total Unre5trithd Restricted fvnd Total funds 2022 2022 2022 2021 2021 2021 Investrnent income 1232 2.520 7.927 8.936 Raising funds Total Unre51ri¢Aed Restricted ftjnds funds Total fvnd$ funds 2022 2022 2021 2021 2021 Fundraisi staging fundraising events Advertising Other fundraising costs Stsff cA)8ts Depreciation and impairmertt 8,174 395 37,935 7,144 9,534 149.134 46.109 4.769 13,359 15,220 11.965 4,769 13.359 15.410 119,928 10.880 167.301 18.167 18. 4.707 4,707 Fundraising and pU1¢ty 28.082 203.747 231.829 23.8fil 134,313 158.173 Tradin Merchandise 13,193 13.193 14.450 14,450 28.082 216.940 245.022 23.860 148.763 172.623
LINGEN DAVIES CANCER FUND CIO NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2022 Charitable activities 2022 2021 Grant funding of .lieS {seÈ mte 8) 829,928 273.784 Share of suptK)rt rA>sts (see note 91 Share of govemance costs (see note 9} 114,1 2.609 79,546 946,727 355.428 Analysi¥ by fund Unrestricted funds Restricted funds 133,897 812,830 196,658 158,770 946.727 355.428 Grants payablè 2022 2021 Grants to insliiutKJns: Clinical Nurse Sp8eialists Clinic Rooms CT Scanner Bladdor Scanner ican Programme Hamar Center Extension Complementary Therdpies GetActive Fed Good Radar Keys Ki(* Cancer 78,677 372,455 440,375 7,059 27,060 59,795 11,100 80,093 3.465 633 10.000 10,OLN) 829.928 273.784 Grants payabl8 from unTestrthd funds to £17.rJ98 12021.. £115.014} and from r8strict8d funds £812,83012021.. £158.Th01. -21_
LINGEN DAVIES CANCER FUND CIO NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2022 Support costs Support Govwnanc• 2022Supwrt (x)sts Goveman (x)sts 2021 96,010 5,4C 8,033 4.743 96.010 75.274 2.087 2.185 75,274 2,087 2.185 DèpreuatKJn Overheads Training 8,033 5.132 AUdt fees Trustee indemnity insLFrar 1.750 1.750 1.740 1.740 470 470 358 114.19) 116.799 79.546 81.644 Anatysed CharitatAe activitss 114.190 116.799 79.546 81,e44 10 Not movement In fvnds 21)22 2021 Net movement in funds is stated after thargil1cK8dilIjI Fees paydble to the (x)MpanS aLMlitor for Ihe audit of the finaniial statements Deprecsation of owned ta[le frxed assets Amorbsation of inl8ngible 8ssets 1,750 1,404 4.000 1,740 6,794 11 Tntsteas N¢)ne of the Trustees lor any peOnS ne(led wilh them) any remunaralion or benefits from the charity during Ihe year. During Ihe year Ihe tharity 1ved donalM)ns ftvm nir* trust (2021". fcAJr). 0(rt conditions totalling £3.756 {2021.' £1.8371. 12 Employo8s The average monthly number OfeM duriro the year Wds: 2022 Numb•r 2021 NuMr AdminiStran
LINGEN DAVIES CANCER FUND CIO NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2022 12 Employ8es {Continu¢dl Employment costs 2022 2021 Wages and salaries ial security costs Other pension costs 224,940 20,074 18.297 162,318 14,234 18,650 263.311 195.202 There were Th) ernOYeeS whose annual remuneratw)n was nKYe than £60.(. 13 Intanglble fixed assets W8b85te Cost At 1 April 2021 Addthons- separately av4uirad 12.0 At 31 March 2022 12.0(KJ Amortlsatlon and impairn*nt At 1 April 2021 Amortisation char for thè year At 31 March 2022 Carying amount At 31 March 2022 8.Otx) At 31 Marth 2021
LINGEN DAVIES CANCER FUND CIO NOTES TO THE FINANCIAL STATEMENTS {CONTINUED) FOR THE YEAR ENDED 31 MARCH 2022 14 Tanglble fixed assets Total At 1 April 2021 Additions 11.055 2.720 13.980 25,035 98,120 95.41KJ At 31 March 2022 13.T75 13.980 95,400 123,155 Depreciation and impaimient At 1 April 2021 DepatiOn charged in the year 7.389 13.9 21,369 1.404 At 31 Marth 2022 8.793 13,980 22,773 Carrying amount At 31 March 2022 4,982 95.41K) l(Kl,382 At 31 March 2021 3.666 3.666 15 Stocks 2022 2021 Finished goods and g(MJds for resale 638 2.219 16 Debtors 2022 2021 Amounts falling due within one year. Trade debtors Prapayments arKI actyu8d income 52,975 182.663 2,000 397,458 235.638 399,458 17 Creditors: amounts tslling due within one year 2022 2021 Accruals and deferred income 858.327 165.102 -24-
e400 0>00 00 i (N ¢J mo otso
LINGEN DAVIES CANCER FUND CIO NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2022 19 D•signatsd funds The inc4Jme funds of 1he charity the frAb) de&gnaled fijnds vthich have been set aside out of unre5thded lunds by the Iwstees for speafic pu)Se5. Movement In funds Irthming Balan¢• at 1 Awil 2021 FE$oUr 31 March Èn funds 1 Awl 2020 2022 Running costs 2.000 200.C 200,000 Anatysls of n•t ass•ts bètw••n funds Totsl Unreslricled Restricted 2022 2021 Total 2021 2022 2022 Fund balances at 31 March 2022 are r6present8d by.. Intsngible fixed assets Tangible assets Current assetsllliabiltbesl 1.382 801.67T 100,382 898,763 3.666 780,258 3,666 1,118,156 97.086 337.898 910.059 97.086 1.007.145 783.924 337.898 1.121.822 21 Purpose of funds {mat•rlal funds onty) Unrestricted funts The unreStrcted reserves r9present a£vIa furKts r1Ved which are free to be led wlhin the obj'ectives ol thè tharity. These fur are a¥aaatrAe for the fvtUTe funding negts and wothng (2pltal of the ch8rity. D•signated r#seTves The running cost reserve is a fund set aside to rn1 the 12 th Nnniryd costs of the d)arity. rf fundin9 sources ceased or reduce4d. Restrlcttd re5erve5 2019-21 Appeal A new ap81 was stsrted in 2019 to raise fvrther fvnds to assist SaTH new projects. We agreed to fundraise approx £370,000 for an extension to the Lingen Dames dinic rooms and £450,000 for a new CT Scanner for thè R8diotherapy dpartenl These projects were delayed by 12 months because of Covid-19 but were Corneted in March 2022. The balan left in the Appeal will be albxated to buying chemolherapy Ccd Caps in 2022123 . with the remain¥ng lunds gn9 to the ican proJecL The charity is wothng wtth NHS ShropshI Telfortl and to deliver the Core20+ proiecL designed lo increase th8 Uptake of S(yeening in Telford afKI Wrekkn.
LINGEN DAVIES CANCER FUND CIO NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2022 Capltal commiti))ents In 8ddtbon to the grants already made in Note 8. 8t the end of year. Ihe Charity has commrtted to pay grants from current fur5 and firture fijnd raising for the followng: Unrestrictsd funth Cool Cap Kick Cancer Holisb"c Therapies ican Programme £18.IXM) £10,OC £11,100 £502.750 23 Related party transactlons RuneratIon of key rnan•gem peTronn81 The remuneration of key m8nagèment persmnd is as folows. 2021 Aggwate Competion 116,¢X)9 97.354 During the year. one empknyee rereNed a diS(x)Un b8ll tKèL whi(a) was availab to 811 ernOyeeS. total sawng of£25. Transaetlons with rolat parties During thè y6ar tnjstees purchased merchaThJise aThJ tets for events from tharity al full cost lotalling £546 {2021.. £1.1951_ Abbeyfest was a pr(4ect in whith Lgen Dawes worked in pathership with shWSbury Abbey and Pop Up Shrop Ltd. Pop Up Shrop Ltd is owned and fflanaged by Daen Tomkins, wFK> is the partner of the Lingen Dawes CEO. 1 of Darren's time was o)mmitted on a volunlary basi8 to the project and all services and purchases invoiwl to the tharity were given at cost price. No profft was made by Pop Up Shrop Ltd hi)m this event. Dyke Yaxley Ltd. in whith MTS F K Hutcheson VRS DirwAor. wiyAied the ¢arrtS a(uxJnting software al an annual cost of £34612021.. £365}, payrdl services at a cost of £30612021.. £4321 and also assist with the preparation of the Finan(aal Statements on a wo txino b" The balan( owed at the year enrj w45 nil ft)r 2022 and 2021. -27-
LINGEN DAVIES CANCER FUND CIO NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 MARCH 2022 24 Cash generated fTom operations 2022 2021 IDefi¢itVsurpu5 forthe year 1114.677) 190.836 Adjustments for.. Invesiment income recognis&Y in statement of fin8nci81 Amortisatson ar inipairrnent of intsngible as5trts Depw#ation and imp8imient of taThJitAe fixed assets (2,5201 18,9361 1,404 6.794 Movements in working Ca1. 1,581 163,820 693,225 609 1241,9261 81.902 Dècreas8llincreasel d8bt<ws Increase in ¢rÈdilors Cash generated from operntions 746.833 29,279